School of Medicine
Showing 1-83 of 83 Results
-
Bing Wang
Postdoctoral Scholar, Stem Cell Transplantation
BioMy academic training and research experience have equipped me with multidisciplinary skills and knowledge of molecular biology and immunology.
I led two projects when I was an undergraduate, in which I got primary academic learning. My team member and I investigated the bacteria content in drinking water from two types of machines that are commonly used in colleges under the guidance of our experimental microbiology teacher Zhihong Zhong. Secondly, we produced a hybridoma cell line secreting monoclonal antibody against the core antigen of the hepatitis C virus (HCV) to develop an ELISA kit for the detection of HCV under the guidance of Dr. Rushi Liu and Minjing Liao.
Thereafter, as a Ph. D. candidate at Xiaoming Feng’s lab, my research primarily focused on understanding the biology of regulatory T cells (Treg) and CD11c+ myeloid cells using cutting-edge single-cell sequencing and conditional knockout mice under healthy and disease conditions. We first revealed the heterogeneity and bifurcated differentiation pathway of human Tregs from normal donors and transplanted patients at the single-cell transcriptome level. A subsequent first and corresponding author publication identified a key innate responsive protein in CD11c+ alveolar macrophages, NRP2, that protects mice from lung injury via promoting the phagocytosis of neutrophils. I also participated in two projects regarding the role of a serine/threonine kinase, LKB1, in mice CD11c+ dendritic cells from lymphoid tissues and adipose tissue with diet-induced obesity. These academic experiences guided me into a strong passion and independent capacities for biomedical studies.
For my postdoctoral training, I will focus on developing Treg therapies and genetic stem cell therapy to cure patients with IPEX syndrome (a severe autoimmune disease) at preclinical and clinical stages, and other immune disorders. My sponsor Dr. Rosa Bacchetta is a well-known leader in treating IPEX patients and developing Treg therapies. My co-mentor Dr. Maria Grazia Roncarolo is a well-recognized pediatric immunologist and also one of the pioneers in the stem cell and gene therapy field, who discovered the type 1 regulatory T cells or Tr1 cells and translate the scientific discoveries into novel Treg therapies. Both of them have an excellent record of training postdoctoral fellows. The proposed projects will provide me with great opportunities in cutting-edge technology and translational research and outline a set of career development including grant writing, public presentation, and lab management, which will enhance my ability to become an independent investigator and help me to reach my goal of developing efficient and safe Treg therapies for a wide range of immune disorders and associated human diseases. -
Jie Wang
Postdoctoral Scholar, Radiology
BioDr. Jie Wang is deeply passionate about magnetic nanotechnology, including magnetic resonance imaging (MRI), magnetic particle imaging (MPI), magnetic nanoparticles (MNPs), magnetic nanofluid hyperthermia (MNFH), magnetic biosensors, etc., for biomedical applications. His dissertation focuses on MRI-guided magnetic hyperthermia for cancer theranostics. Currently, his research interests include developing enzyme-activable nanoparticles for brain cancer theranostics and employing multi-modal imaging modalities to investigate the interaction between nanoparticles and biosystems (nano-bio interaction) within tumor microenvironment.
-
Jinglong Wang
Postdoctoral Scholar, Radiation Biology
BioDr. Wang was trained at the Jacques Monod Institute and École Normale Supérieure in Paris, France under the mentorship of Dr. Terence Strick. and obtained his Ph.D. degree from the University of Paris in 2019. He dissected the molecular machinery of human and bacterial NHEJ, and interrogated the mechanism of SpCas9 tolerance to non-specific substrate using single-molecule nanomanipulation tools.
Jinglong’s research in the Frock Lab focuses on DSB-related chromosome topological changes and genomic interactions. -
Mengxiong Wang
Postdoctoral Scholar, Radiation Biology
Current Research and Scholarly Interests1. To investigate the role of p53 in regulating the regression of lung adenocarcinoma and tumor microenvironment.
2. To determine synthetic lethal partner for p53 mutations in the context of lung adenocarcinoma. -
Wenjun Wang
Postdoctoral Scholar, Stem Cell Transplantation
Current Research and Scholarly InterestsMy postdoctoral research focuses on investigating novel therapy for childhood leukemias.
-
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Lianna Wat
Postdoctoral Scholar, Pathology
BioLianna obtained her Ph.D. in Cell and Developmental Biology in Dr. Elizabeth Rideout’s lab at the University of British Columbia in 2021 where she studied the sex-specific regulation of fat metabolism using Drosophila as a model system. Lianna is bringing her expertise on sex differences and fat metabolism to the Svensson lab where she is interested in understanding in discovering secreted metabolic effectors that regulate male-female differences in energy metabolism and the development of metabolic disease
-
Brian Wayda
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsHeart transplant policy and outcomes, cost-effectiveness, mathematical modeling
-
Alexis Thomas Weiner
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Rain Runxia Wen
Postdoctoral Scholar, Ophthalmology
BioRain Runxia Wen obtained her B.Sc. (Hons) in biology in 2012, and her Ph.D. degree in cell and developmental biology in 2018. She joined the Goldberg Lab in the Department of Ophthalmology at Stanford University in 2019. She is currently developing epigenetic tools to promote neuroregeneration, especially retinal ganglion cell, and optic nerve regeneration.
-
Shannon White
Postdoctoral Scholar, Genetics
BioHi, I'm Shannon White. I began my postdoctoral fellowship in Michael Snyder's lab in the fall of 2020. I received my PhD from Georgetown University in Tumor Biology in Chunling Yi's lab. My graduate worked explore the signaling and metabolic vulnerabilities of NF2-mutant tumors following YAP/TAZ depletion. My postdoctoral work is exploring the epigenetic hallmarks that contribute to colon cancer progression and drug resistance. I am developing colon organoids derived from pre-cancerous polyp tissue collected from Familial Adenomatous Polyposis patients as a model system to investigate epigenetic and signaling responses to chemoprevention treatments.
-
Britni Wilcher
Postdoctoral Scholar, Health Policy
BioBritni Wilcher, PhD, is a Postdoctoral Fellow in Health Services Research & Development. Dr. Wilcher earned her PhD in economics from American University in 2022. She is an applied microeconomist with interests in health, labor, and gender economics. Dr. Wilcher’s research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs to draw causal inferences for historically disadvantaged populations. While completing her doctoral studies, Dr. Wilcher also conducted impact analysis of US regulations for think tanks and government agencies.
Prior to her doctoral studies, Dr. Wilcher completed a BA in Economics at Spelman College and MSc in International Health Care Management, Economics, and Policy at SDA Bocconi School of Management in Milan, Italy. During her masters, she specialized in the economics evaluation of pharmaceutical and medical devices. Dr. Wilcher applied that training as a senior consultant at Booz Allen Hamilton in Washington, DC and research fellow at the University of Exeter in England. Her work at Exeter, supporting an EU commission aimed at advancing the existing methodological framework for health technology assessment (HTA) of medical devices (MedtecHTA), was published in Value in Health, Health Economics, and the International Journal of Technology Assessment in Health Care. -
Joseph Winer
Postdoctoral Scholar, Neurology and Neurological Sciences
BioJoe Winer completed his PhD in Psychology at UC Berkeley working with Matthew Walker and William Jagust. During his PhD, Joe used overnight EEG and PET imaging to investigate connections between sleep disruption and Alzheimer's disease in the context of healthy aging. At Stanford, Joe's research combines wearable devices, neuroimaging, and other biomarkers to explore how tracking sleep and other factors in everyday life can provide information about brain health and cognitive trajectories in aging and neurodegenerative diseases.
-
Emily Woods
Postdoctoral Scholar, Pathology
Current Research and Scholarly Interestsdevelopment of activity-based probes for specific diagnosis and treatment of Staphylococcus aureus infections
-
Caren Yu-Ju Wu
Postdoctoral Scholar, Neurosurgery
Current Research and Scholarly InterestsBasic, translational, immunological and clinical research
-
Yue Wu
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsI built computational methods to integrate and model biological time series, including metabolic dynamics, longitudinal multi-omics data, and micro-sampling. I reduce dimensions, built clusters, and search for causal links.